3SBIO (01530.HK) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec2

3SBio Inc. Conducts Private Placement of New Shares

00:14

Dec1

Sensing Pharma Sell Shares to Raise Funds for Global and China R&D

11:50

Nov28

JPMorgan 上调 Sino Legend 目标价并维持买入评级，Sino Legend plans to spin off Mandy International

02:37

Nov27

Guotai Junan Securities Raises Target Price for Tris Pharma and Maintains Overweight Rating

03:58

Sanomics Announces 707 Clinical Data, Pfizer Unveils Global Clinical Strategy for 707

01:39

Nov26

Hua Tian Fu Fund Increased Holdings in Sino Biological to 6.01%

11:20

Schedules & Filings

Schedules

Filings

Aug29

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 2.384 B, Net Income 743.29 M, EPS 0.3064

Aug15

Distribution Plan(CST)

Cash dividend 0.25 HKD

Jul22

Distribution Plan(CST)

Cash dividend 0.25 HKD

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change